Gottschau Mathilde, Mellemkjaer Lene, Hannibal Charlotte G, Kjaer Susanne K
Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark.
Department of Gynecology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Acta Obstet Gynecol Scand. 2016 Oct;95(10):1181-9. doi: 10.1111/aogs.12948. Epub 2016 Aug 20.
The Nordic countries are areas with a high-incidence of ovarian cancer; however, differences between the countries exist.
We used the Danish Cancer Registry to identify 11 264 cases of ovarian cancer and 363 cases of tubal cancer during 1993-2013. We calculated age-standardized (world standard population) incidence rates for overall and subtype-specific ovarian cancer, and for tubal cancer. We compared age-standardized incidence rates, and 1- and 5-year age-standardized relative survival rates, respectively, for ovarian and tubal cancer combined in four Nordic countries using the NORDCAN database.
The incidence rate of ovarian cancer overall in Denmark decreased statistically significantly by approximately 2.3% per year among women aged <70 years, whereas no change was seen among women aged 70+ years. In the <70-year age-group, the incidence of serous tumors was fairly steady, whereas that of other and unspecified epithelial tumors decreased significantly by 6.4% per year. The incidence of tubal cancer was quite stable. In Norway and Finland, the incidence rates of ovarian and tubal cancer combined decreased from 1993 to 2013 in women aged <70 years, whereas in Sweden the incidence rates decreased independently of age. The 1- and 5-year relative survival rates of ovarian and tubal cancer combined increased during the study period in all the Nordic countries. Denmark had the lowest survival; however, the survival rates approached those of the other countries in recent years.
In Denmark, the positive development in ovarian cancer has continued during recent years with a lower incidence and an increased survival.
北欧国家是卵巢癌高发地区;然而,各国之间存在差异。
我们利用丹麦癌症登记处,确定了1993年至2013年间11264例卵巢癌病例和363例输卵管癌病例。我们计算了总体及特定亚型卵巢癌以及输卵管癌的年龄标准化(世界标准人口)发病率。我们使用北欧癌症数据库,分别比较了四个北欧国家卵巢癌和输卵管癌合并后的年龄标准化发病率、1年和5年年龄标准化相对生存率。
丹麦70岁以下女性卵巢癌总体发病率每年在统计学上显著下降约2.3%,而70岁及以上女性未见变化。在70岁以下年龄组中,浆液性肿瘤的发病率相当稳定,而其他和未明确的上皮性肿瘤的发病率每年显著下降6.4%。输卵管癌的发病率相当稳定。在挪威和芬兰,1993年至2013年间,70岁以下女性卵巢癌和输卵管癌合并后的发病率下降,而在瑞典,发病率下降与年龄无关。在研究期间,所有北欧国家卵巢癌和输卵管癌合并后的1年和5年相对生存率均有所提高。丹麦的生存率最低;然而,近年来其生存率已接近其他国家。
在丹麦,近年来卵巢癌持续呈现积极的发展态势,发病率降低且生存率提高。